Background. The association between bacteremia by Streptococcus gallolyticus subsp. gallolyticus (SGG) and colorectal neoplasia (CRN) is well established but the frequency of the association varies widely in different studies. We conducted a case-control study to assess the association between SGG bacteremia and CRN.
Background. The association between bacteremia by Streptococcus gallolyticus subsp. gallolyticus (SGG) and colorectal neoplasia (CRN) is well established but the frequency of the association varies widely in different studies. We conducted a case-control study to assess the association between SGG bacteremia and CRN.
Methods. An analysis of all SGG bacteremias was performed during the period 1988-2011. The frequency of CRN in patients with SGG bacteremia was compared with the frequency of CRN in a symptomatic control group of patients matched at a 1:2 ratio for gender and age (±3 years) without S. bovis bacteremia and personal history of CRN and with increased risk of CRN (by the presence of symptoms, signs, or test suspicious of colonic pathology or by family history of CRN).
Results. One hundred nine cases of SGG bacteremia were detected (mean age, 66 years; 87% male). Colonoscopy was performed in 98 cases, diagnosing 69 cases of CRN: 57 adenomas (39 advanced adenomas) and 12 invasive carcinomas. Only 4 cases had suspected CRN before the blood culture. The prevalence of CRN was higher in patients with SGG bacteremia than in the 196 control patients (70% vs 32%; odds ratio [OR], 5.1; 95% confidence interval [CI], 3.0-8.6). This difference was not significant when comparing nonadvanced adenomas (19% vs 12%), but we found significant differences in advanced adenomas (40% vs 16%; OR, 3.5; 95% CI, 2.0-6.1) and invasive carcinomas (12% vs 5%; OR, 2.9; 95% CI, 1.2-6.9).
Conclusions. The frequency of CRN among SGG infected patients is significantly increased compared with symptomatic age-matched controls, indicating that SGG infection is a strong indicator for underlying occult malignancy.
Since the 1970s, the association of Streptococcus bovis bacteremia with colorectal neoplasia (CRN) has been well known [1] . The taxonomy of the S. bovis/equinus group has undergone significant changes over the past decade, but still there is no consensus about the designation of these microorganisms, and the use of the term S. bovis is still widespread. Using the scheme proponed by Schlegel et al [2] on the basis of DNA studies, isolates with clinical relevance in humans include: Streptococcus gallolyticus subsp. gallolyticus (former S. bovis biotype I) (SGG), S. gallolyticus subsp. pasteurianus (former S. bovis biotype II/2), and Streptococcus infantarius subsp. coli and subsp. infantarius (former S. bovis biotype II/1). The biotypes II/1 and II/2 have been associated with hepatobiliary infections, and SGG has been associated with endocarditis and CRN [3] . The frequency of this last association varies widely in different studies [1, [3] [4] [5] [6] [7] [8] . These differences depend on the proper evaluation of the bowel, the characterization of the S. bovis biotype/genospecies, and probably of geographic differences [8, 9] .
Although some studies report a relationship between S. bovis and benign lower bowel pathology [5, 6, 10] or extra-intestinal malignancy [11] [12] [13] , it is unclear whether this association is true or coincidental.
Therefore the primary aim of our study was to evaluate the frequency of CRN in patients with SGG bacteremia undergoing colonoscopy and compare this frequency with that of a control group matched by age and sex. As a secondary objective, we assessed whether there were differences in the frequency of other types of intestinal pathology or noncolorectal cancer.
METHODS
We conducted a case-control study to compare the frequency of CRN in cases of SGG bacteremia with the frequency in a population composed of patients at increased risk of CRN. We also analyzed the presence of benign colorectal diseases and noncolorectal cancer in the 2 groups. We studied prospectively all episodes of bacteremia due to SGG from 1988 to May 30 2011. Significant bacteremia was defined using the Weinstein criteria [14] . Infective endocarditis (IE) was defined according to the modified Duke criteria [15] .
Strains were stored at −70°C in Difco skim milk (Becton Dickinson and Company) until required. The biochemical identification was performed by 2 methods: the API 20 Strep (bioMérieux) and the GP card of the VITEK 2 system (bioMérieux). For molecular identification, the complete 16S ribosomal RNA gene sequence was determined [10] .
A case was defined as a patient who had bacteremia caused by SGG and had undergone complete colonoscopic evaluation. The colon was examined up to the cecum by conventional methods in all patients during their admission, unless contraindicated or there was lack of consent. If colonoscopic examination had been incomplete because of technical problems, it was repeated as many times as necessary. All visible polyps were removed and sent to the pathology laboratory for histological examination.
A control was defined as a patient free of SGG bacteremia who had undergone complete colonic evaluation. Controls were selected from a group of patients without previous diagnosis of a colorectal tumor who had undergone colonoscopy between 1988 and 2011 for a clinical suspicion of colorectal disease or who were asymptomatic patients but had a family history of colorectal cancer. The indications for colonoscopy in the control group were rectal bleeding (76 cases), chronic diarrhea (20 cases), abdominal pain (19 cases), change in bowel habits (15 cases), presence of fecal occult blood (7 cases), constipation (6 cases), study of iron deficiency anemia (22 cases), family history of CRN (18 cases), and other (13 cases). Cases and controls were matched at a 1:2 ratio for both gender and age (±3 years).
Colorectal neoplasia included both adenoma and carcinoma. Advanced adenoma was defined as an adenoma with a diameter of ≥1 cm, or tubulovillous (25%-75% of villous component) or villous (>75%) histology, or high-grade dysplasia. Carcinoma in situ was classified as adenoma with high-grade dysplasia. The criterion for invasive cancer was the presence of malignant cells beyond the muscularis mucosa (16 
RESULTS

General Characteristics of the Study Group
During the study period, 109 patients with SGG bacteremia were identified, accounting for 65% of the bacteremias due to S. bovis group and 0.9% of all bloodstream infections in our center. Thirty-four percent of the episodes occurred between 2006 and 2011. The mean age of patients was 66.3 years (median, 69 years; range, 24-92 years); 87% of patients were male. The most frequent consult reasons were fever and/or toxic syndrome (66%). In 97% of the cases, ≥2 blood cultures were positive. Two episodes of bacteremia were polymicrobial. Overall, 79% of patients had IE; the differences between patients with IE and bacteremia are summarized in Table 1 . Thirteen patients (12%) died during their admission; all deaths were related with bacteremia (12 due to IE and 1 due to sepsis).
Association With Colorectal Tumors
In 11 of the 109 cases, colonoscopy was not performed: in 8 cases, the patient had died; in 2 cases, the patient had a disseminated noncolorectal cancer; and in 1 case, the patient did not provide consent. These cases were excluded from our case-control study. In the remaining 98 patients (90%), a colonoscopy was performed: 69 were diagnosed of CRN, although CRN had been clinically suspected before colonoscopy in only 4 of these cases. In a directed questioning that followed the blood culture results, only 11 of the 69 patients of CRN (16%) explained symptoms suggestive of colorectal pathology (7 had constipation, 2 had blood in stool, and 2 had rectal bleeding). Sixty-two percent of the patients had anemia, but it was always anemia of chronic disorder typical of IE (with high ferritin). The histology, size, number, and location of these tumors are summarized in Tables 2 and 3 . In 54 cases, the CRN was endoscopically removed (4 of them with gastrointestinal bleeding that was resolved medically); in 13 patients, surgery was required (1 patient died after surgery); and in 2 patients, surgery was not possible due to their advanced age and comorbidity. Chemotherapy was administered in 5 cases. When compared with the control group, the presence of CRN, advanced adenomas, and invasive carcinomas was significantly higher in patients with SGG bacteremia (Table 4) . We found no differences in the location or the number of tumors per patient between groups.
Association With Other Diseases
Seven patients had noncolonic cancer: 1 lymphoma and 6 carcinomas (pancreas, biliary, liver, kidney, ovary, and lung). All these cancers had been diagnosed prior to bacteremia (1-19 months before; average, 10.3 months). In contrast, only 4 of the 69 CRN cases had been diagnosed before bacteremia (9-39 months before) (P < .001). Four of these 7 patients had undergone colonoscopy, and CRN (adenomas) was detected in 3 of them.
Despite the presence of diverticulum in the colonoscopy being very common (35 cases), only 3 patients had acute diverticulitis. Other benign pathologies found at colonoscopy are shown in Table 4 . There were no differences in the percentages of benign bowel disease or noncolorectal cancer in patients with SGG bacteremia when compared with the control group (Table 4) .
DISCUSSION
Association With Colorectal Tumors
To our knowledge this is the first case-control study that included >100 cases of SGG bacteremia that investigated the prevalence of underlying CRN reported from a single center. Ninety percent of our patients underwent colonoscopy, one of the highest rates ever published [1, 3-8, 10-13, 17-22] . Despite knowledge of the association between S. bovis bacteremia and CRN, it is surprising that even in recent reports the colon was not examined [10, 20] in a high number of cases. Reasons such as associated comorbidity conditions, presence of an extraintestinal focus (although this does not exclude a CRN [23] ), or an absence of symptoms avoided the colonoscopy.
Although it is well known that this attitude may have fatal consequences [24] . The frequency of CRN varies widely in different reports; it depends mainly on the percentage of cases that are biotype I and of the proper study of the colon. The prevalence of CRN (adenomas and carcinomas) in these cases varies 55%-73% [1, 18, 19, 25, 26] . These percentages are much higher than those reflected in studies of colon cancer screening in the general population [16, [27] [28] [29] , even when compared with those performed on an elderly population with a high percentage of males, as was done in the study by Lieberman [16] , which was conducted in veteran hospitals and among those with a high incidence of tumors. Comparing our patients, also mostly elderly males, with those in the aforementioned study, we found significant differences in the frequency of advanced adenomas and invasive carcinomas but not in nonadvanced adenomas, which are common among the elderly population, with most not evolving into cancer [30] . To eliminate possible bias (age, sex, geographic differences), we chose a control group adjusted for age and sex. The only case-control study conducted previously excluded patients with intestinal bleeding [25] . We selected cases with increased risk of CRN by the presence of symptoms, signs, or family history of CRN [31, 32] . In fact, the percentage of advanced adenomas and carcinomas found in the control group was higher than that found in the general population of similar age and sex [16, 28, 29] . Nevertheless, the association with CRN was much higher in patients with SGG bacteremia, although most of these cases were asymptomatic. The reason that these tumors behaved as an occult malignancy in most cases was that only a minority of them were invasive cancers. Only 6% of our patients with CRN had lymph node or distant metastasis, and only 4% had tumors >4 cm in diameter.
In a published review of 310 colonic neoplasms associated with S. bovis bacteremia, only 67 (22%) were carcinomas [33] .
Few studies specify histological type of these tumors; in those that do, as in our series, the advanced adenomas were predominant [5, 6, 18, 19] . In the few reports in which the stage of carcinoma was specified, a significant proportion of carcinomas were noninvasive [1, 6, 19, 22] . This may be related to the presence of serum antibodies against the SGG antigen, as noted in a recent study [34] . The humoral immune response against SGG antigens was significantly increased in patients with early stages of CRN compared with asymptomatic healthy controls and patients with late stages of CRN.
There is a strong association between SGG and IE [7, 35] , nearly 8 out of 10 of our patients with SGG bacteremia had IE. There is no clear understanding of the mechanisms by which SGG spreads from the gut to cause IE. The bacteria can easily penetrate the bloodstream in ulcerating colorectal carcinomas, but most of these tumors are nonulcerating small adenomas. An elegant experimental study by Boleij et al [36] analyzed the virulence characteristics that allow SGG to cross the intestinal barrier, evade the immune system, and form biofilms in collagen-rich surfaces such as heart valves. This collagen-binding ability may be important for the penetration of SGG across to nonulcerating small adenomas.
We found a similar percentage of CRN in patients with IE and bacteremia, although the latter had a higher frequency of carcinomas, perhaps because these patients were older. Only 2 previous reports compared the incidence of CRN in patients with IE and patients with bacteremia due to S. bovis [6, 22] . In these reports, the percentage of CRN was significantly lower in patients with bacteremia; but in the report in which biotype identification was performed, most of the episodes of bacteremia were caused by S. bovis biotype II [22] . 
Association With Other Diseases
SGG bacteremia does not seem related with other benign pathologies that we have occasionally found by colonoscopy in patients with and without CRN. A common finding was the presence of a diverticular disease, but this disease is very frequent in elderly patients in developed countries, and there was no difference with the control group. We had 3 patients who had acute diverticulitis but did not have CRN. We think that the cause of the bacteremia in these 3 cases was the diverticulitis. One of these patients was, however, diagnosed with an advanced adenoma in the sigmoid 42 months later. It is unclear whether SGG is associated with other noncolorectal cancers. In 2 extensive reviews of the literature [33, 37] , the relationship appears weak, but in 3 studies [11] [12] [13] , about one-quarter of patients had noncolorectal cancer associated with bacteremia due to S. bovis. We did not find a higher percentage of noncolorectal cancers in patients with SGG than in the control group. However, we found a strong association of noncolorectal digestive cancer with S. infantarius bacteremia [38] . It is likely that the reported cases in the literature were also due to biotype II [11] [12] [13] . Regardless, the presence of another type of cancer does not rule out the association with CRN, an association that happened in 3 of our patients, and it should be investigated if the patient's life expectancy is good.
To summarize, we found that patients with SGG bacteremia have a strong association with CRN; this association is significantly higher than that in symptomatic controls. However, it is unknown whether this relationship is a consequence of CRN or whether it could also have a causal component in CRN development [39] [40] [41] . On the other hand, we found no connection between SGG bacteremia and benign colorectal diseases or noncolorectal cancer. Further studies are needed to confirm our findings and understand the mechanism involved. b Symptoms: rectal bleeding, abdominal pain, chronic diarrhea, change of bowel habit, blood mixed with stools, constipation.
c Some patients had >1 lesion (eg, diverticular disease, adenoma, and hyperplasic polyps).
